fludarabine and orlistat

fludarabine has been researched along with orlistat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Debey, S; Hallek, M; Kofler, D; Königs, S; Pallasch, CP; Schultze, JL; Schulz, A; Schwamb, J; Ultsch, A; Wendtner, CM	1

Other Studies

1 other study(ies) available for fludarabine and orlistat

Article	Year
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia, 2008, Volume: 22, Issue:3 Topics: Apoptosis; B-Lymphocytes; Drug Screening Assays, Antitumor; Drug Synergism; Fatty Acids, Nonesterified; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lipid Metabolism; Lipoprotein Lipase; Multigene Family; Neoplasm Proteins; Orlistat; Phospholipases; Proto-Oncogene Proteins c-bcr; Tumor Cells, Cultured; Vidarabine	2008

Article

Year

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.

Leukemia, 2008, Volume: 22, Issue:3

Topics: Apoptosis; B-Lymphocytes; Drug Screening Assays, Antitumor; Drug Synergism; Fatty Acids, Nonesterified; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lipid Metabolism; Lipoprotein Lipase; Multigene Family; Neoplasm Proteins; Orlistat; Phospholipases; Proto-Oncogene Proteins c-bcr; Tumor Cells, Cultured; Vidarabine

2008